NCT05259280View on ClinicalTrials.gov

Observational Study of the Wellinks Solution Impact on Quality of Life and Clinical Outcomes in Patients With COPD

NACompletedINTERVENTIONAL
Enrollment

153

Participants

Timeline

Start Date

January 5, 2022

Primary Completion Date

September 8, 2022

Study Completion Date

September 8, 2022

Conditions
COPDChronic Obstructive Pulmonary DiseaseChronic Obstructive Pulmonary Disease SevereChronic Obstructive Pulmonary Disease Moderate
Interventions
OTHER

Wellinks

Digital health and virtual care program for COPD management.

Trial Locations (2)

20002

COPD Foundation, Washington D.C.

06511

Wellinks, New Haven

Sponsors
All Listed Sponsors
collaborator

COPD Foundation

OTHER

lead

Convexity Scientific Inc

INDUSTRY

NCT05259280 - Observational Study of the Wellinks Solution Impact on Quality of Life and Clinical Outcomes in Patients With COPD | Biotech Hunter | Biotech Hunter